Resource Archive
To provide resources that are scientifically evaluated, relevant, and engaging to CBOs, clinicians, and other health agencies that can be used in their offices or on their social media.
Filter Resources
Disease
Audience
Format
Management
Post-Covid Conditions and Surveillances Post-COVID-19 syndrome involves a variety of new, returning or ongoing symptoms that may be experienced several weeks after getting COVID-19. In some people, post-COVID-19 syndrome lasts months or years or causes disability. The National Institutes of Health (NIH) created the RECOVER Initiative, a research project that aims to understand how people recover from a COVID-19 infection and why some people do not fully recover and develop long COVID or post-acute sequelae of SARS-CoV-2 (PASC). Anyone can participate in the RECOVER project, including those who have COVID-19 now, had COVID-19 before, or never had COVID-19. People of all races and ethnicities, genders, ages, and locations will be included in the research project to better understand how long COVID affects people. Select Prospective Cohort Studies on post-COVID conditions and related topics: • O’Laughlin KN, Thompson M, Hota B, Gottlieb M, Plumb ID, Chang AM, Wisk LE, Hall AJ, Wang RC, Spatz ES, Stephens KA, Huebinger RM, McDonald SA, Venkatesh A, Gentile N, Slovis BH, Hill M, Saydah S, Idris AH, Rodriguez R, Krumholz HM, Elmore JG, Weinstein RA, Nichol G; INSPIRE Investigators. Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection. PLoS One. 2022 Mar 3;17(3). • Han JH, Womack KN, Tenforde MW, Files DC, Gibbs KW, Shapiro NI, Prekker ME, Erickson HL, Steingrub JS, Qadir N, Khan A, Hough CL, Johnson NJ, Ely EW, Rice TW, Casey JD, Lindsell CJ, Gong MN, Srinivasan V, Lewis NM, Patel MM, Self WH; Influenza and Other Viruses in the Acutely Ill (IVY) Network. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza Other Respir Viruses. 2022 Mar 28.
CDC guidelines on patient qualification for COVID-19 boosters and when it can be administered
Interview of Serena Marshall, Track the Vax host, with Dial Hewlett Jr., M.D., medical director for Westchester County, New York, and deputy to the commissioner for the Westchester County Department of Health
Seeing people dying from diseases that may be preventable or severity lessened with combinations of utilization of vaccine guidelines and policies combined with prevention strategies especially in crowded situations.. As influenza hospitalization rates are increasing in the United States (US), Respiratory Syncytial Virus (RSV) causing maximum utilization of pediatric inpatient facilities, and COVID-19 still causing hospitalization especially in the elderly and those with pre-existing co-morbid medical conditions, there is a crises in respiratory illnesses early in the current season.
BlackDoctor.org hosted a Facebook Live event where NIH’s Dr. Anthony Fauci joined a conversation with the Black Coalition Against COVID-19 to discuss COVID-19 vaccines. In addition to Dr. Fauci, the conversation featured Howard University president Dr. Wayne Frederick, infectious disease specialist Dr. Siham Mahgoub, National Urban League president Marc Morial, and Ambrose Lane Jr., chair of the Health Alliance Network
A recently-issued misleading and potentially dangerous public statement, delivered by a high-ranking, elected official regarding the COVID-19 vaccine poses a clear danger to public health. It is for this reason that the Task Force on Vaccines and Therapeutics of the National Medical Association (NMA) feels obligated to issue the following support for the current FDA-approved COVID-19 vaccines.
Updates for Healthcare Professionals: Topics included COVID-19 – Variants and Bivalent Vaccines, Respiratory Syncytial, Virus (RSV), Influenza Vaccines, Monkeypox (MPOX) – Overview of Outbreak and Disparities
This report is a consolidation of findings related to COVID-19 vaccines for children from CDC’s COVID-19 State of Vaccine Confidence Report (SoVC) #20, SoVC #21, and SoVC #22 reflecting data collected from November 9, 2021, through January 10, 2022.
The W. Montague Cobb/National Medical Association (NMA) Health Institute (The Cobb Institute), a 501(c)(3) in Washington, DC, functions as a national consortium of scholars that engages in innovative research and knowledge dissemination for the reduction and elimination of racial and ethnic health disparities and racism in medicine. Solving one of our society’s most pressing problems, racial inequities in health, requires the collaborative work of public agencies, private entities, academic medical centers, and -- equally important -- communities. Founded in 2004, The Institute is named in honor of the late William Montague Cobb M.D., Ph.D., physician, anthropologist, and a distinguished professor of medicine and anatomy. Dr. Cobb influenced countless graduates of Howard University School of Medicine, including Randall C. Morgan, Jr., M.D., M.B.A. who is an orthopedic surgeon and Founding Executive Director of The Cobb Institute.